
Glyoxalase in tumourigenesis and multidrug resistance
Keywords: AGE; advanced glycation endproduct; ALL; acute lymphoid leukaemia; AML; acute myeloid leukaemia; BBGD; S-p-bromobenzylglutathione cyclopentyl diester; CEdG; N2-(1-carboxyethyl)-deoxyguanosine; CEL; NÉ-carboxyethyl-lysine; CrML; chronic myeloid leukaemia;